A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects.
Cancer medicine（2023）
摘要
ClinicalTrials.gov NCT04033419.
更多查看译文
关键词
behavioral science,breast cancer,cancer-related cognitive impairment,clinical trials,cognitive dysfunction,memantine,quality of life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要